ChristopherWilleyMDPhD

Central Nervous System Cancer, Head & Neck, Thoracic Cancer

Professor and Associate Vice Chair of Translational Research, Department of Radiation Oncology, University of Alabama at Birmingham School of Medicine

Join to view full profile

Dr. Willey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Willey's full profile

Already have an account?

Office
1717 6th Ave S
Birmingham, AL 35233
Phone+1 800-822-8816

Summary

Dr. Christopher Willey is a radiation oncologist in Birmingham, AL and is affiliated with multiple hospitals in the area, including Birmingham Veterans Affairs Medical Center, Children's of Alabama, Cooper Green Hospital, and University of Alabama Hospital. He received his medical degree from Medical University of South Carolina College of Medicine and has been in practice 14 years. He specializes in central nervous system cancer, head & neck, and thoracic cancer.

Education & Training

Vanderbilt University Medical CenterResidency, Radiation Oncology, 2004 - 2008
Spartanburg Medical CenterInternship, Transitional Year, 2003 - 2004
Medical University of South CarolinaClass of 2003

Certifications & Licensure

AL State Medical License 2008 - 2025
SC State Medical License 2003 - 2004
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema Start of enrollment: 2021 Sep 23
Active, not recruiting
Not Applicable
Roles: Principal Investigator

Publications & Presentations

PubMed

A High-Throughput Neurosphere-Based Colony Formation Assay to Test Drug and Radiation Sensitivity of Different Patient-Derived Glioblastoma Lines.
Manoj Kumar, Lauren C Nassour-Caswell, Hasan Alrefai, Joshua C Anderson, Taylor L Schanel
Cells. 2024-12-03
Altering fractionation during radiation overcomes radio-resistance in patient-derived glioblastoma cells assessed using a novel longitudinal radiation cytotoxicity assay.
Lauren C Nassour-Caswell, Manoj Kumar, Christian T Stackhouse, Hasan Alrefai, Taylor L Schanel
Radiotherapy and Oncology. 2024-11-21
2 citations
Exploring Gut Microbiota Alterations with Trimethoprim-Sulfamethoxazole and Dexamethasone in a Humanized Microbiome Mouse Model.
George B H Green, Alexis N Cox-Holmes, Olivia Backan, Olivia Valbak, Anna Claire E Potier
Microorganisms. 2024-05-17

Press Mentions

Melanoma Treatment: Potential Target Bypasses Therapeutic Resistance to Immune Checkpoint BlockersSeptember 16th, 2022
Drinking Even a Single Glass of Alcohol Can Trigger a Heart Condition, Study RevealsSeptember 18th, 2021
UAB Researchers Identify Potential Therapeutic Target Against Malignant Brain TumorsApril 5th, 2021
Join now to see all